Association of a common TLR-6 polymorphism with coronary artery disease – implications for healthy ageing?

Monocyte tissue factor–dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin

(2012) A. Phillip Owens et al.   JOURNAL OF CLINICAL INVESTIGATION

Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists

(2012) Linda K. Curtiss et al.   JOURNAL OF LIPID RESEARCH

Genetic Signatures of Exceptional Longevity in Humans

(2012) Paola Sebastiani et al.   PLoS One

Therapeutic role of toll-like receptor modification in cardiovascular dysfunction

(2012) Ali Navi et al.   VASCULAR PHARMACOLOGY

Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity

(2011) Taro Kawai et al.   IMMUNITY

Association of Human TLR1 and TLR6 Deficiency with Altered Immune Responses to BCG Vaccination in South African Infants

(2011) April Kaur Randhawa et al.   PLoS Pathogens

Toll-Like Receptor 6 Ser249Pro Polymorphism Is Associated With Lower Left Ventricular Wall Thickness and Inflammatory Response in Hypertensive Women

(2010) M. L. Sales et al.   AMERICAN JOURNAL OF HYPERTENSION

Apolipoprotein CIII Induces Monocyte Chemoattractant Protein-1 and Interleukin 6 Expression Via Toll-Like Receptor 2 Pathway in Mouse Adipocytes: Retracted

(2010) Yasuko Abe et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Inflammation in Atherosclerosis:

(2010) Peter Libby et al.   CIRCULATION JOURNAL

Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin-6 secretion

(2010) M S Shey et al.   GENES AND IMMUNITY

Toll like receptor 4 in atherosclerosis and plaque destabilization

(2009) Wijnand K. den Dekker et al.   ATHEROSCLEROSIS

Finding the missing heritability of complex diseases

(2009) Teri A. Manolio et al.   NATURE

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

(2009) Cameron R Stewart et al.   NATURE IMMUNOLOGY

StoneHinge: Hinge prediction by network analysis of individual protein structures

(2009) Kevin S. Keating et al.   PROTEIN SCIENCE

Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted

(2008) Akio Kawakami et al.   CIRCULATION RESEARCH

Target Flexibility: An Emerging Consideration in Drug Discovery and Design†

(2008) Pietro Cozzini et al.   JOURNAL OF MEDICINAL CHEMISTRY

Toll-Like Receptor-2 Mediates Diet and/or Pathogen Associated Atherosclerosis: Proteomic Findings

(2008) Monika Madan et al.   PLoS One